lactic acid has been researched along with Cicatrix in 37 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy and histologic differences of intradermal injection of a filler (poly-d, l-lactic acid, PDLA) using an MFRF device for the treatment of acne scars." | 9.51 | Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial. ( Hyeong, JH; Jung, JW; Kim, HS; Kim, KH; Seo, SB, 2022) |
| "To determine the degree of correction attainable with poly-L-lactic acid and safety findings for the treatment of hill and valley acne scarring." | 9.20 | A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. ( Mraud, K; Sapra, S; Schupp, R; Stewart, JA, 2015) |
| "This report describes a novel use of injectable poly-L-lactic acid (PLLA; Sculptra) for the correction of acne scars in an adult patient." | 7.75 | Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. ( Palmisano, L; Sadick, NS, 2009) |
| "To investigate the efficacy and histologic differences of intradermal injection of a filler (poly-d, l-lactic acid, PDLA) using an MFRF device for the treatment of acne scars." | 5.51 | Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial. ( Hyeong, JH; Jung, JW; Kim, HS; Kim, KH; Seo, SB, 2022) |
| "Acne vulgaris affects up to 80% of people 11 to 30 years of age, and scarring can occur for up to 95% of these patients." | 5.35 | Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. ( Sadove, R, 2009) |
| "Acne scars may negatively impact quality of life." | 5.34 | A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. ( Beer, K, 2007) |
| "To determine the degree of correction attainable with poly-L-lactic acid and safety findings for the treatment of hill and valley acne scarring." | 5.20 | A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring. ( Mraud, K; Sapra, S; Schupp, R; Stewart, JA, 2015) |
| "The Jessner's-trichloroacetic acid (TCA) peel is a procedure developed by Monheit to produce a safe, effective medium-depth chemical peel for the treatment of photoaged skin, actinic keratoses, and superficial acne scars." | 4.79 | The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel. ( Monheit, GD, 1995) |
| "This report describes a novel use of injectable poly-L-lactic acid (PLLA; Sculptra) for the correction of acne scars in an adult patient." | 3.75 | Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. ( Palmisano, L; Sadick, NS, 2009) |
| "Polylactic acid glue can effectively reduce epidural cicatrization and adhesion." | 3.73 | Effect of polylactic acid glue in preventing epidural scar adhesion after laminectomy in rabbits. ( Ding, YL; Duan, H; Liu, LM; Lu, B; Song, YM, 2006) |
| "The incidence of inflammation, suppuration and hypertrophic scarring was recorded, along with the timing of spontaneous suture disappearance." | 2.69 | Outcomes of irradiated polyglactin 910 Vicryl Rapide fast-absorbing suture in oral and scalp wounds. ( Aderriotis, D; Sàndor, GK, 1999) |
| "Corticosteroids may be beneficial in treating vocal fold scarring." | 1.42 | Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts. ( Kosinski, AM; Panitch, A; Pothen, JM; Sivasankar, MP, 2015) |
| "Atrophic scars represent a loss of collagen and a challenging reconstructive dilemma with disappointing traditional treatments." | 1.40 | Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. ( Ozog, D; Rkein, A; Waibel, JS, 2014) |
| " We found that MMWC was toxic for two parasite forms." | 1.39 | In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study. ( Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B, 2013) |
| "Although antiscarring agents help prevent postsurgical scarring and improve glaucoma surgical outcomes, they may be associated with an increased incidence of severe and potentially blinding complications." | 1.39 | Effect of poly(DL-lactide-co-glycolide) on scar formation after glaucoma filtration surgery. ( DU, LQ; Li, Y; Wang, SG; Wu, XY; Yang, HL, 2013) |
| "Acne vulgaris affects up to 80% of people 11 to 30 years of age, and scarring can occur for up to 95% of these patients." | 1.35 | Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. ( Sadove, R, 2009) |
| "For the glabellar region, severe partly vascular adverse events have been reported after treatment with injectable fillers." | 1.35 | The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. ( Bachmann, F; Erdmann, R; Hartmann, V; Rzany, B; Wiest, L, 2009) |
| "Acne scars may negatively impact quality of life." | 1.34 | A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. ( Beer, K, 2007) |
| "However, fragile scar adhered with dura mater diffusely and more FB were observed in CG." | 1.33 | [Experimental study on the polylactic acid glue in preventing epidural adhesion]. ( Ding, Y; Duan, H; Liu, L; Lu, B; Song, Y, 2005) |
| "We observed a dense, fibrous scar and encapsulation at the implantation site." | 1.32 | Complications of bioabsorbable orbital implants and fixation plates. ( Burgett, R; Huynh, TH; Ng, JD, 2004) |
| "Epidural scar formation and adhesion were observed grossly and histologically." | 1.32 | [Experimental study on the prevention of epidural scar adhesion with polycaprolactone/polylactic acid membrane]. ( Ji, HR; Pang, XD; Xiao, G; Xu, XX; Yan, JJ; Yang, CD; Yu, DH; Zhang, ZW; Zhu, D, 2004) |
| "Multiple modalities are available for treating acne scars, one of which is chemical peeling." | 1.31 | Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. ( Al-Sharqi, AI; Al-Waiz, MM, 2002) |
| "The results of treating hypertrophic scars with urea preparations are also to be evaluated optimistically." | 1.26 | [Formation and treatment of pathologic scars--clinical and micromorphologic investigations (author's transl)]. ( Auböck, L; Bayer, U; Kerl, H, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.11) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 15 (40.54) | 29.6817 |
| 2010's | 10 (27.03) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Hyeong, JH | 3 |
| Jung, JW | 3 |
| Seo, SB | 3 |
| Kim, HS | 3 |
| Kim, KH | 3 |
| Ali, B | 1 |
| ElMahdy, N | 1 |
| Elfar, NN | 1 |
| Gutiérrez, J | 1 |
| Vallejo, B | 1 |
| Barbosa, H | 1 |
| Pinzón, J | 1 |
| Delgado, G | 1 |
| DU, LQ | 1 |
| Yang, HL | 1 |
| Wu, XY | 1 |
| Wang, SG | 1 |
| Li, Y | 1 |
| Rkein, A | 1 |
| Ozog, D | 1 |
| Waibel, JS | 1 |
| Kosinski, AM | 1 |
| Pothen, JM | 1 |
| Panitch, A | 1 |
| Sivasankar, MP | 1 |
| Sapra, S | 1 |
| Stewart, JA | 1 |
| Mraud, K | 1 |
| Schupp, R | 1 |
| Fife, DJ | 1 |
| Dhall, S | 1 |
| Silva, JP | 1 |
| Liu, Y | 1 |
| Hrynyk, M | 1 |
| Garcia, M | 1 |
| Chan, A | 1 |
| Lyubovitsky, J | 1 |
| Neufeld, RJ | 1 |
| Martins-Green, M | 1 |
| Sadove, R | 1 |
| Sadick, NS | 1 |
| Palmisano, L | 1 |
| Bachmann, F | 1 |
| Erdmann, R | 1 |
| Hartmann, V | 1 |
| Wiest, L | 1 |
| Rzany, B | 1 |
| Guyot, A | 1 |
| Carbonnel, M | 1 |
| Frey, C | 1 |
| Pharisien, I | 1 |
| Uzan, M | 1 |
| Carbillon, L | 1 |
| Sachdeva, S | 1 |
| Lee, SY | 1 |
| Oh, JH | 1 |
| Kim, JC | 1 |
| Kim, YH | 1 |
| Kim, SH | 1 |
| Choi, JW | 1 |
| Ng, JD | 1 |
| Huynh, TH | 1 |
| Burgett, R | 1 |
| Huang, JJ | 1 |
| Song, YM | 2 |
| Liu, LM | 2 |
| Liu, L | 1 |
| Song, Y | 1 |
| Duan, H | 2 |
| Ding, Y | 1 |
| Lu, B | 2 |
| Zhang, ZW | 1 |
| Xu, XX | 1 |
| Yang, CD | 1 |
| Pang, XD | 1 |
| Ji, HR | 1 |
| Yan, JJ | 1 |
| Zhu, D | 1 |
| Xiao, G | 1 |
| Yu, DH | 1 |
| Wiggers, H | 1 |
| Nørrelund, H | 1 |
| Nielsen, SS | 1 |
| Andersen, NH | 1 |
| Nielsen-Kudsk, JE | 1 |
| Christiansen, JS | 1 |
| Nielsen, TT | 1 |
| Møller, N | 1 |
| Bøtker, HE | 1 |
| Choi, YS | 1 |
| Park, SN | 1 |
| Suh, H | 1 |
| Lowe, NJ | 1 |
| Ding, YL | 1 |
| Vleggaar, D | 1 |
| Beer, K | 1 |
| Lee, CK | 1 |
| Alexander, H | 1 |
| Kerl, H | 1 |
| Auböck, L | 1 |
| Bayer, U | 1 |
| In de Braekt, MM | 3 |
| Maltha, JC | 3 |
| Kuijpers-Jagtman, AM | 3 |
| Monheit, GD | 1 |
| Van Alphen, FA | 2 |
| Heino, A | 1 |
| Naukkarinen, A | 1 |
| Kulju, T | 1 |
| Törmälä, P | 1 |
| Pohjonen, T | 1 |
| Mäkelä, EA | 1 |
| Reed, JT | 1 |
| Joseph, AK | 1 |
| Bridenstine, JB | 1 |
| Aderriotis, D | 1 |
| Sàndor, GK | 1 |
| Demas, PN | 1 |
| Braun, TW | 1 |
| Al-Waiz, MM | 1 |
| Al-Sharqi, AI | 1 |
| Mikawa, Y | 1 |
| Hamagami, H | 1 |
| Shikata, J | 1 |
| Higashi, S | 1 |
| Yamamuro, T | 1 |
| Hyon, SH | 1 |
| Ikada, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 6 Month Double-Blind Randomized Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Small Particle Hyaluronic Acid to Treat Acne Scars Located on the Cheeks and Forehead[NCT02955381] | 26 participants (Actual) | Interventional | 2017-03-28 | Terminated (stopped due to Liquidation of Research Department) | |||
| Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces[NCT02312154] | Phase 4 | 25 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"We measured a elasticity by a reviscometer device (Courage & Khazaka, Cologne, Germany).~The range of elasticity was 0 (most elastic possible as) ~400 AU(Arbitrary Unit) (inelastic as possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 242.33 |
| Untreated Side | 271.15 |
"We measured an erythema index by a mexameter device (Courage & Khazaka, Cologne, Germany).~The range of erythema index is 0~999 AU(Arbitrary Unit). The range of erythema index was 0 (as non-erythematous as possible) ~999 AU (most erythematous possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 253.66 |
| Untreated Side | 243.53 |
The therapeutic outcome was assessed by investigator using the Global Aesthetic Improvement Scale (GAIS), which rates outcome on the following 5-point scale: 3, very much improved; 2, much improved; 1, improved; 0, no change; and -1, worse. (NCT02312154)
Timeframe: 12 weeks
| Intervention | scores on a scale (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 1.38 |
| Untreated Side | 0 |
The therapeutic outcome was assessed by patient self-assessment using the Global Aesthetic Improvement Scale (GAIS), which rates outcome on the following 5-point scale: 3, very much improved; 2, much improved; 1, improved; 0, no change; and -1, worse (NCT02312154)
Timeframe: 12 weeks
| Intervention | scores on a scale (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 1.33 |
| Untreated Side | 0 |
"We measured a hydration level by a corneometer device (Courage & Khazaka, Cologne, Germany).~The range of hydration level was 0 (as dry as possible) ~120 AU (Arbitrary Unit)(most moist possible)" (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 53.19 |
| Untreated Side | 46.75 |
"We measured a melanin index by a mexameter device (Courage & Khazaka, Cologne, Germany).~The range of melanin index was 0 (as bright as possible) ~999 AU (Arbitrary Unit) (most dark possible)." (NCT02312154)
Timeframe: 12 weeks
| Intervention | AU (arbitrary unit) (Mean) |
|---|---|
| Treated Side (Restylane Vital) | 147.25 |
| Untreated Side | 149.00 |
1 review available for lactic acid and Cicatrix
| Article | Year |
|---|---|
The Jessner's-trichloroacetic acid peel. An enhanced medium-depth chemical peel.
Topics: Acne Vulgaris; Chemexfoliation; Cicatrix; Drug Combinations; Ethanol; Face; Facial Dermatoses; Human | 1995 |
6 trials available for lactic acid and Cicatrix
| Article | Year |
|---|---|
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Intradermal Injection of Poly-d, l-Lactic Acid Using Microneedle Fractional Radiofrequency for Acne Scars: An Open-Label Prospective Trial.
Topics: Acne Vulgaris; Cicatrix; Humans; Injections, Intradermal; Lactic Acid; Prospective Studies | 2022 |
Microneedling (Dermapen) and Jessner's solution peeling in treatment of atrophic acne scars: a comparative randomized clinical study.
Topics: Acne Vulgaris; Chemexfoliation; Cicatrix; Combined Modality Therapy; Cosmetic Techniques; Drug Combi | 2019 |
A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Biocompatible Materials; Canada; Cicatrix; Cosmetic | 2015 |
[Clinical study of prevention of epidural scar and adhesion with polylactic acid membrane].
Topics: Adult; Aged; Biocompatible Materials; Cicatrix; Diskectomy; Female; Humans; Intervertebral Disc Disp | 2004 |
Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium.
Topics: Aged; Blood Glucose; Chronic Disease; Cicatrix; Cross-Over Studies; Diastole; Drug Combinations; Ech | 2005 |
Outcomes of irradiated polyglactin 910 Vicryl Rapide fast-absorbing suture in oral and scalp wounds.
Topics: Adult; Biocompatible Materials; Cicatrix; Humans; Lactic Acid; Mouth; Oral Surgical Procedures; Poly | 1999 |
30 other studies available for lactic acid and Cicatrix
| Article | Year |
|---|---|
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibro | 2013 |
Effect of poly(DL-lactide-co-glycolide) on scar formation after glaucoma filtration surgery.
Topics: Animals; Biocompatible Materials; Cicatrix; Filtering Surgery; Glaucoma; Lactic Acid; Polyglycolic A | 2013 |
Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Atrophy; Cicatrix; Collagen; Dermatologic Agents | 2014 |
Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.
Topics: Biocompatible Materials; Cells, Cultured; Cicatrix; Collagen; Cytokines; Delayed-Action Preparations | 2015 |
Commentary on a Canadian study of the use of poly-L-lactic Acid dermal implant for the treatment of hill and valley acne scarring.
Topics: Biocompatible Materials; Cicatrix; Face; Female; Humans; Lactic Acid; Male; Patient Satisfaction; Po | 2015 |
Release of insulin from PLGA-alginate dressing stimulates regenerative healing of burn wounds in rats.
Topics: Administration, Cutaneous; Alginates; Animals; Bandages; Burns; Chemistry, Pharmaceutical; Cicatrix; | 2015 |
Injectable poly-L: -lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne.
Topics: Acne Vulgaris; Chronic Disease; Cicatrix; Esthetics; Female; Humans; Injections, Intradermal; Lactic | 2009 |
Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars.
Topics: Acne Vulgaris; Cellulose; Cicatrix; Female; Humans; Injections, Intradermal; Lactic Acid; Mannitol; | 2009 |
The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Cicatrix; Dermatologic Agents; Drug Combina | 2009 |
[Uterine rupture: risk factors, maternal and perinatal complications].
Topics: Adult; Apgar Score; Birth Injuries; Blood Transfusion; Cesarean Section; Cicatrix; Cohort Studies; F | 2010 |
Lactic acid peeling in superficial acne scarring in Indian skin.
Topics: Acne Vulgaris; Adult; Cicatrix; Female; Humans; India; Keratolytic Agents; Lactic Acid; Pilot Projec | 2010 |
In vivo conjunctival reconstruction using modified PLGA grafts for decreased scar formation and contraction.
Topics: Animals; Cell Adhesion; Cell Division; Cells, Cultured; Cicatrix; Conjunctiva; Epithelium, Corneal; | 2003 |
Complications of bioabsorbable orbital implants and fixation plates.
Topics: Absorbable Implants; Biocompatible Materials; Bone Plates; Cicatrix; Eyelid Diseases; Humans; Intern | 2004 |
[Experimental study on the polylactic acid glue in preventing epidural adhesion].
Topics: Adhesives; Animals; Biocompatible Materials; Cicatrix; Epidural Space; Female; Fibroblasts; Lactic A | 2005 |
[Experimental study on the prevention of epidural scar adhesion with polycaprolactone/polylactic acid membrane].
Topics: Animals; Biocompatible Materials; Cicatrix; Female; Lactic Acid; Laminectomy; Membranes, Artificial; | 2004 |
Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres.
Topics: Adipocytes; Adipose Tissue; Alcian Blue; Animals; Anthraquinones; Azo Compounds; Blotting, Western; | 2005 |
Dispelling the myth: appropriate use of poly-L-lactic acid and clinical considerations.
Topics: Acne Vulgaris; Biodegradation, Environmental; Cicatrix; Humans; Lactic Acid; Polyesters; Polymers; P | 2006 |
Effect of polylactic acid glue in preventing epidural scar adhesion after laminectomy in rabbits.
Topics: Animals; Biocompatible Materials; Cicatrix; Lactic Acid; Laminectomy; Membranes, Artificial; Polyest | 2006 |
Soft-tissue augmentation and the role of poly-L-lactic acid.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Cicatrix; Cosmetic Techniques; Face; Female | 2006 |
A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella.
Topics: Acne Vulgaris; Adult; Biocompatible Materials; Chickenpox; Cicatrix; Cosmetic Techniques; Face; Fema | 2007 |
Prevention of postlaminectomy scar formation.
Topics: Animals; Cicatrix; Dogs; Lactates; Lactic Acid; Laminectomy; Lumbar Vertebrae; Polyesters; Polymers; | 1984 |
[Formation and treatment of pathologic scars--clinical and micromorphologic investigations (author's transl)].
Topics: Adolescent; Adult; Betaine; Child; Cicatrix; Collagen; Drug Combinations; Female; Glycosaminoglycans | 1981 |
Poly-(L-lactic) acid membranes in palatal surgery in beagle dogs: clinical and histologic evaluation.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Cicatrix; Collagen; Connective Tiss | 1995 |
Maxillary arch dimensions after palatal surgery and implantation of poly-(L-lactic) acid membranes in beagle dogs.
Topics: Analysis of Variance; Animals; Cicatrix; Dental Arch; Dogs; Lactates; Lactic Acid; Maxilla; Membrane | 1993 |
Characteristics of poly(L-)lactic acid suture applied to fascial closure in rats.
Topics: Abdominal Muscles; Animals; Cicatrix; Lactic Acid; Male; Microscopy, Electron, Scanning; Polyesters; | 1996 |
Treatment of periorbital wrinkles. A comparison of the SilkTouch carbon dioxide laser with a medium-depth chemical peel.
Topics: Administration, Cutaneous; Adult; Aged; Carbon Dioxide; Chemexfoliation; Cicatrix; Drug Combinations | 1997 |
Chemical skin resurfacing.
Topics: Anesthesia, Local; Chemexfoliation; Cicatrix; Dermatologic Agents; Dermatologic Surgical Procedures; | 1998 |
Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals.
Topics: Acne Vulgaris; Adolescent; Adult; Caustics; Chemexfoliation; Cicatrix; Drug Combinations; Drug Thera | 2002 |
Wound healing and wound contraction after palatal surgery and implantation of poly-(L-lactic) acid membranes in beagle dogs.
Topics: Analysis of Variance; Animals; Cicatrix; Dogs; Lactates; Lactic Acid; Membranes, Artificial; Palate; | 1992 |
An experimental study on prevention of postlaminectomy scar formation by the use of new materials.
Topics: Animals; Biocompatible Materials; Cicatrix; Lactates; Lactic Acid; Laminectomy; Membranes, Artificia | 1986 |